Adoptive transfer of experimental allergic encephalomyelitis after in vitro treatment with recombinant murine interleukin-12: Preferential expansion of interferon-γ-producing cells and increased expression of macrophage-associated inducible nitric oxide synthase as immunomodulatory mechanisms

American Journal of Pathology

Volumn 148, Issue 2, 1996, Pages 375-382

  Waldburger, Kristine E ^a   Hastings, Richard C ^a   Schaub, Robert G ^a   Goldman, Samuel J ^a   Leonard, John P ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4; NITRIC OXIDE SYNTHASE; PROTEOLIPID PROTEIN; RECOMBINANT INTERLEUKIN 12;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EFFECTOR CELL; GENE EXPRESSION; HELPER CELL; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; INTERFERON PRODUCTION; LYMPH NODE CELL; LYMPHOCYTIC INFILTRATION; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BRAIN CHEMISTRY; CELLS, CULTURED; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FREUND'S ADJUVANT; IMMUNOENZYME TECHNIQUES; IMMUNOTHERAPY, ADOPTIVE; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MYELIN PROTEOLIPID PROTEIN; NITRIC OXIDE SYNTHASE; RECOMBINANT PROTEINS; TH1 CELLS;

EID: 0030039962     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Alvor EC Jr, Kies MW, Suckling AJ. Experimental allergic encephalomyelitis, a useful model for multiple sclerosis New York, Alan R Liss, 1984
2. Pettinelli CB, Fritz RB, Chou C-H, MacFarlin DE: Encephalitogenic activity of guinea pig myelin basic protein in the SJL mouse. J Immunol 1982, 129:1209
3. Tuohy VK, Sobel RA, Lees MB: Myelin proteolipid protein induced experimental allergic encephalomyelitis: variations of disease expression in different strains of mice. J Immunol 1988, 140:1868-1873
4. +2 T lymphocytes. J Immunol 1981, 127:1420-1423
5. Kuchroo VK, Martin CA, Greer JM, Ju S-T, Sobel RA, Dorf ME. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein specific T cell clones to mediate experimental allergic encephalomyelitis. J Immunol 1993, 151.4371-4382
6. Merrill JE, Kono DH, Clayton J, Ando DG, Hinton DR, Hofman F: Inflammatory leukocytes and cytokines in the peptide induced disease of experimental allergic encephalomyelitis in SJL/J and B10.PL mice. Proc Natl Acad Sci USA 1992, 89 574-578
7. Baron JL, Madri JA, Ruddle NH, Hashim Q, Janeway CA Jr: Surface expression of α4 integrin by CD4 T cells is required for their entry into brain parenchyma. J Exp Med 1993, 177.57-68
8. Kennedy MK, Torrance DS, Picha KS, Mohler KM Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J Immunol 1992, 149:2496-2505
9. Kuchroo VK, Martin CA, Greer JM, Ju S-T, Sobel RA, Dorf ME: Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein specific T cell clones to mediate experimental allergic encephalomyelitis. J Immunol 1993, 151:4371-4382
10. Yednock TA, Cannon C, Fritz LC, Sanchez-Madrid F, Steinman L, Karin K Prevention of experimental autoimmune encephalomyelitis by antibodies against α4β1 integrin Nature 1992, 356.63-66
11. Huitinga I, van Rooijen N, de Groot CJA, Uitdehaag BMJ, Dijkstra CD. Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages J Exp Med 1990, 172.1025
12. Ruddle NH, Bergman CM, McGrath KM, Lingenheld EG, Grunnet ML, Padula SJ, Clark RB An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis J Exp Med 1990, 172:1193-1200
13. Jacobs CA, Baker PE, Roux ER, Picha KS, Toivola B, Waugh S, Kennedy MK Experimental autoimmune encephalomyelitis is exacerbated by IL-1α and suppressed by soluble IL-1 receptor J Immunol 1991, 146:2983-2989
14. Ovadia H, Lehmann D, Kol-Mizrachi R, Abramsky O. Inhibition of experimental allergic encephalomyelitis by nitric oxide synthase inhibitor Neurology 1994, 44: 466P
15. Wolf SF, Temple PA, Kobayashi M, Young D, Dicig M, Lowe L, Dzialo R, Fitz L, Ferenz C, Hewick RM, Kelleher K, Herrmann SH, Clark SC, Azzoni L, Chan SH, Trinchieri G, Perussia B: Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biological effects on T and natural killer cells. J Immunol 1991, 146.3074-3081
16. Manetti R, Parronchi P, Giudizi MG, Piccinni MP, Maggi E, Trinchieri G, Romagnani S Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4 producing Th cells J Exp Med 1993, 177:1199-1204
17. Sypek JP, Chung CL, Mayor SE, Subramanyam JM, Goldman SJ, Sieburth DS, Wolf SF, Schaub RG Resolution of cutaneous leishmaniasis: interleukin-12 initiates a protective T helper type 1 immune response J Exp Med 1993 177 1797-1802
18. Heinzel FP, Schoenhaut DS, Rerko RM, Rosser LE, Gately MK: Interleukin-12 when administered multiple times systemically to Balb/c mice during infection enhances their resistance to L. major J Exp Med 1993, 177:1505-1509
19. Leonard JP, Waldburger KE. Goldman SJ Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12 J Exp Med 1995, 181. 381-386
20. Morris SC, Madden KB, Adamovicz JI, Gause WC, Hubbard BR, Gately MK, Finkelman FD: Effects of IL-12 on in vivo cytokine gene expression and Ig isotype expression. J Immunol 1994, 152:1047-1056
21. Racke MK, Bonomo A, Scott DE, Canella B, Levine A, Raine CS, Shevach EM, Rocken M Cytokine induced immune deviation as a therapy for inflammatory autoimmune disease. J Exp Med 1994, 180:1961-1966
22. Kuchroo VK, Das M, Brown JA, Ranger AM, Zamvil SS, Sobel RA, Weiner HL, Nabavi N, Glimcher LH. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 development pathways: application to autoimmune disease therapy. Cell 1995, 80:707-718
23. Campbell IL, Samimi A, Chiang C-S: Expression of the inducible nitric oxide synthase: correlation with neuropathology and clinical features in mice with lymphocytic choriomeningitis. J Immunol 1994, 153:3622-3629
24. Merrill JE, Ignarro LJ, Sherman MP, Melinek J, Lane TE: Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide J Immunol 1993, 151:2132-2141
25. Ding AH, Nathan CF, Stuehr DJ. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production J Immunol 1988, 141:2407
26. Duong TT, St Louis J, Gilbert JJ, Finkelman FD, Strejan GH: Effect of anti-interferon-γ and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse. J Neuroimmunol 1992, 36.105-115
27. Rott O, Fleisher B, Cash E: Interleukin 10 prevents experimental allergic encephalomyelitis in rats. Eur J Immunol 1994, 24.1434-1440
28. Cash E, Minty E, Ferrara P, Caput D, Fradelizi D, Rott O: Macrophage-inactivating IL-13 suppresses experimental autoimmune encephalomyelitis in rats J Immunol 1994, 153:4258-4267